Evgen Pharma PLC Company Profile (LON:EVG)

About Evgen Pharma PLC

Evgen Pharma PLC logoEvgen Pharma PLC is a United Kingdom-based clinical-stage drug development company. The Company's lead programs are focused on the treatment of cancers, such as breast and prostate cancer, and neurological conditions, such as subarachnoid hemorrhage. The Company has completed Phase I trials for its development product, SFX-01. It is carrying out preclinical work in relapsing remitting multiple sclerosis. It is also conducting preclinical work for two sulforaphane analogues, SFX-02 and SFX-03 for nuclear respiratory factor (Nrf) 2 activation, anti-cancer activity and genotoxicity. The Company's core technology is Sulforadex, a synthetic and stabilized version of a plant derived compound, sulforaphane, which is an anti-cancer agent. Sulforadex is a complex of sulforaphane and alpha-cyclodextrin in a stable powder, which is in a group of compounds known as antioxidant inflammation modulators (AIMs), affects the activity of transcription factors and thereby influencing gene expression.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: EVG
  • CUSIP:
Key Metrics:
  • Previous Close: $0.34
  • 50 Day Moving Average: $27.25
  • 200 Day Moving Average: $20.90
  • 52-Week Range: GBX 14.50 - GBX 45
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $17.63M
  • Outstanding Shares: 73,142,000
Additional Links:

Analyst Ratings

Consensus Ratings for Evgen Pharma PLC (LON:EVG) (?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: GBX 88

Analysts' Ratings History for Evgen Pharma PLC (LON:EVG)
Show:
DateFirmActionRatingPrice TargetDetails
9/15/2016Northland SecuritiesReiterated RatingBuyGBX 97View Rating Details
8/18/2016Beaufort SecuritiesDowngradeHoldView Rating Details
1/4/2016Northland Capital PartnersReiterated RatingBuyGBX 79View Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for Evgen Pharma PLC (LON:EVG)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Evgen Pharma PLC (LON:EVG)
Current Year EPS Consensus Estimate: $4.90 EPS

Dividends

Dividend History for Evgen Pharma PLC (LON:EVG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Evgen Pharma PLC (LON:EVG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/18/2016Clare,BarryInsiderBuy40,000GBX 22£8,800
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Evgen Pharma PLC (LON:EVG)
DateHeadline
ft.com logoUpdate re SFX-01 Data at ECTRIMS 2016 (LON:EVG)
announce.ft.com - September 15 at 5:30 AM
proactiveinvestors.co.uk logoNorthland Capital Partners View on the City - Botswana Diamonds, Evgen Pharma plc (LON:EVG)
www.proactiveinvestors.co.uk - September 9 at 9:44 AM
morningstar.co.uk logoEvgen Pharma Shares Rise On Back Of Teaser For SFX-01 Results (LON:EVG)
www.morningstar.co.uk - September 8 at 4:50 PM
ft.com logoPresentation of SFX-01 Data at ECTRIMS 2016 (LON:EVG)
announce.ft.com - September 8 at 4:50 PM
trustnet.com logoEvgen Pharma gets FDA orphan designation (LON:EVG)
www.trustnet.com - August 25 at 9:53 AM
proactiveinvestors.co.uk logoNorthland Capital Partners View on the City - Evgen Pharma plc, James Latham plc (LON:EVG)
www.proactiveinvestors.co.uk - August 25 at 9:53 AM
reuters.com logoBRIEF-Evgen Pharma granted orphan drug designation for stabilised sulforaphane (LON:EVG)
www.reuters.com - August 24 at 4:51 PM
News IconEvgen Pharma plc Clinical Trial Approval for Phase II Study in Breast Cancer (LON:EVG)
www.bioportfolio.com - August 24 at 4:51 PM
4-traders.com logoEvgen Pharma : Says SFX-01 Granted Orphan Drug Designation In US (LON:EVG)
www.4-traders.com - August 24 at 4:51 PM
proactiveinvestors.co.uk logoNorthland Capital Partners View on the City - Evgen Pharma plc (LON:EVG)
www.proactiveinvestors.co.uk - August 17 at 5:49 AM
4-traders.com logoEvgen Pharma : Gains Approval For SFX-01 Breast Cancer Phase II Clinical Trial (LON:EVG)
www.4-traders.com - August 17 at 5:49 AM
live-pr.com logoSubarachnoid Hemorrhage Global Clinical Trials Review, H1, 2016 - New Market Report (LON:EVG)
www.live-pr.com - June 7 at 9:26 AM
4-traders.com logoEvgen Pharma : Pleased With "Significant Progress" Since AIM Listing (LON:EVG)
www.4-traders.com - June 1 at 11:11 PM
biz.yahoo.com logoFull Year 2016 Evgen Pharma PLC Earnings Release - Time Not Supplied (LON:EVG)
biz.yahoo.com - May 31 at 7:07 AM
stockhouse.com logoNotification of Preliminary Results (LON:EVG)
www.stockhouse.com - May 9 at 10:29 AM
iii.co.uk logoEVGEN PHARMA (LON:EVG)
www.iii.co.uk - May 4 at 9:52 AM
trustnet.com logoEvgen Pharma Plc to present at the SHARES Investor Evening in London on 19th May (LON:EVG)
www.trustnet.com - May 3 at 10:07 AM
thestreet.com logoOsteoarthritis Pipeline Market H1 2016 Global Review Report (LON:EVG)
www.thestreet.com - April 28 at 10:18 AM
News IconPipeline of Multiple Sclerosis Market H2 2015 Review Research (LON:EVG)
www.free-press-release-center.info - March 8 at 8:44 AM
proactiveinvestors.co.uk logoBeaufort Securities Breakfast Alert - Tertiary Minerals, Alecto Minerals, Motif Bio and others (LON:EVG)
www.proactiveinvestors.co.uk - March 3 at 8:46 AM
trustnet.com logoApproval of Phase II Clinical Trial in SAH (LON:EVG)
www.trustnet.com - March 2 at 8:47 AM
News IconOsteoarthritis H2 2015 market pipeline scrutinized in new research (LON:EVG)
www.whatech.com - February 12 at 8:17 AM
finance.yahoo.com logoOsteoarthritis Therapeutics Pipeline Review, H2 2015 - Research and Markets (LON:EVG)
finance.yahoo.com - February 9 at 4:59 PM
morningstar.co.uk logoCORRECT: DIRECTOR DEALINGS: Evgen Pharma Directors Buy 136,000 Shares (LON:EVG)
www.morningstar.co.uk - January 20 at 7:26 AM
stockmarketwire.com logoEvgen Pharma Ord 0.25p (LON:EVG)
www.stockmarketwire.com - January 19 at 7:36 AM
morningstar.co.uk logoDIRECTOR DEALINGS: Evgen Pharma Directors Bought 136,000 Shares (LON:EVG)
www.morningstar.co.uk - January 19 at 7:36 AM
trustnet.com logoEvgen Pharma PLC (EVG) (LON:EVG)
www.trustnet.com - January 19 at 7:36 AM

Social


Last Updated on 9/30/2016 by MarketBeat.com Staff